Michael Pan, MD

Work Experience

Hair Transplant Surgeon
Parsa Mohebi Hair Restoration
Los Angeles, CA

Kaiser Permanente
Los Angeles, CA
October 2019 – December 2021

Visiting Dermatologist
Princess Marina Hospital
Gaborone, Botswana
August 2018 – September 2018

Post-Graduate Training

Dermatology Chief Resident
Mount Sinai Health System
New York, NY
July 2016 – June 2019

Transitional Year Resident
University of Hawaii Residency Programs
Honolulu, HI
July 2015 – June 2016

Medical School

Doctor of Medicine (M.D.)
Icahn School of Medicine at Mount Sinai School
New York, NY
August 2011 – May 2015


Common FUE Graft Harvesting Problems and Solutions
Parsa Mohebi, MD, Michael Pan, MD
Hair Transplant Forum International
March/April 2023, Vol. 33, Number 2, Pages 49, 54056
Los Angeles, CA

Moskalenko M, Pan M, Fu Y, de Moll E, Hashimoto D, Mortha A, Leboeuf M, Jayaraman P, Sikora A, Wolchok J, Bhardwaj N, Merad M, Saenger Y. Requirement for innate immunity and NK1.1-CD90+ lymphocytes to treat established melanoma with chemo- immunotherapy. Cancer Immunology Research, 2015 Mar;3(3):296-304. PMID: 25600438.

Pan M, Geller L. Update on Indoor Tanning Legislation in the United States. Clinics in Dermatology. January 2014. doi:10.1016/j.clindermatol.2014.12.016

Pan M, Harcharik S, Moskalenko M, Luber A, Bernardo S, Levitt J. Instructional Video for Teaching Venepuncture. The Clinical Teacher. 2014 Oct;11(6):436-41. PMID: 25212929

Torbeck R, Pan M, de Moll E, Levitt J. Cantharidin: a comprehensive review of the clinical literature. Dermatology Online Journal. June 2014: 20(6). PMID: 24945640

Harcharik S, Bernardo S, Moskalenko M, Pan M, Sivendran M, Bell H, Cordon-Cardo C, Sivendran S, Phelps R, Saenger Y. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage II-III cutaneous melanoma. Journal of the American Academy of Dermatology. June 2014;70(6):1036-44. PMID: 24698703

Sivendran S, Chang R, Pham L, Phelps R, Harcharik S, Hall L, Bernardo S, Moskalenko M, Sivendran M, Fu Y, de Moll E, Pan M, et al. Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Anti-Tumor Surveillance of Patients with Stage II-III Resectable Disease. Journal of Investigative Dermatology. August 2014;134(8):2202-11 PMID: 24522433

Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the literature. Dermatology Online Journal. November 2013 19(11) PMID: 24314769

Emer J, Pan M, Bernardo S, Sidhu H. A Young Boy With Itchy Papules on the Trunk. J Clin Aesthet Dermatol. Apr 2013; 6(4): 43– 45. PMID: 23630643

Bernardo S, Geraghty L, Freilich A, Pan M, Lebwohl M. Frequency of monotherapy versus combination therapy in reported cases of infections occurring in the setting of biologic agents. Psoriasis Forum June 2013: 19(1):2-15.

Goldufsky J, Sivendran S, Harcharik S, Pan M, Bernardo S, Stern RH, Friedlander P, Ruby CE, Saenger Y, Kaufman HL. Oncolytic virus therapy for cancer. Oncolytic Virotherapy. September 2013. 2:31-46

Bernardo SG, Moskalenko M, Pan M, Shah S, Sidhu HK, Sicular S, Harcharik S, Chang R, Friedlander P, Saenger Y. Elevated rates of transaminitis during ipilimumab therapy for metastatic melanoma. Melanoma Res. February 2013;23(1):47–54. PMID: 23262440

Sivendran S, Glodny B, Pan M, Merad M, Saenger Y. Melanoma immunotherapy. Mt Sinai J Med. 77(6):620–642. 2010.

Sivendran S, Pan M, Kaufman H, Saenger Y. Herpes simplex virus oncolytic vaccine therapy in melanoma. Expert Opinion onBiological Therapy July 2010 10(7), 1145-1153. PMID: 20515292

Pan M, Moskalenko M, Hashimoto D, Bernardo S, Wolchok JD, Houghton A, Burakoff S, Merad M, Saenger Y. Therapeutic efficacy of anti-tumor monoclonal antibodies combined with chemotherapy depends on innate immunity. Eighteenth Annual Medical Student Research Day, Icahn School of Medicine at Mount Sinai, November 8, 2012. Selected for oral presentation.

Pan M, Harcharik S, Moskalenko M, Luber A, Shah S, Bernardo S, Heinecke G, Bernardo M, Chomsky N, Levitt J. The use of an instructional video improves venipuncture technique and safety. Education Research Day, Icahn School of Medicine at Mount Sinai, April 30, 2013. Blue Ribbon recipient.

Pan M, Harcharik S, Bernardo S, Heinecke G, Moskalenko M, Luber A, Shah S, Levitt J. Use of video instruction to improve safety of venipuncture. Northeast Group on Educational Affairs 2013 Annual Retreat, New York, NY, April 12-14, 2013.

Saenger Y, Pan M, Hashimoto D, Silvin A, Kwan W, Houghton A, Merghoub T, Wolchok JD, Merad M. Anti-tyrosinase related protein 1 antibody in combination with cyclophosphamide causes regression and CD8+ T cell infiltration of established B16 melanoma. International Melanoma Congress of the Society for Melanoma Research, Sydney, AUS, November 2010

Pan M, Sivendran S, Saenger Y. Combination Treatment of Anti-Tyrosinase Related Protein-1 Monoclonal Antibody with Chemotherapy in Melanoma. Consortium for Graduate Medical Education, New York, NY, June 2010

Board and Licensure Information

American Board of Dermatology – 2019

Medical Board of California – active

Honors and Awards

Chief Resident in Dermatology, Mount Sinai Health System

Resident International Grant, American Academy of Dermatology

Graduation with Distinction in Research, Icahn School of Medicine at Mount Sinai

Arnold P. Gold Humanism Honor Society, Icahn School of Medicine at Mount Sinai